NFKB1 and lung carcinoma: Additionally, we included three cases of patients with comorbidities of lung cancer; since our gene data showed enrichment in the BCR, ECM, NF-κB, and TNF signaling pathways, which are all related to inflammation and tumor, we can’t exclude the possibility of false positive results due to tumor progression [36–38].